Estimates of cancer incidence and mortality in Europe in 2008, European Journal of Cancer, vol.46, issue.4, pp.765-81, 2010. ,
DOI : 10.1016/j.ejca.2009.12.014
Les cancers de l???ovaire : incidence et mortalit?? en France, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.34, issue.2, pp.34-154, 2005. ,
DOI : 10.1016/S0368-2315(05)82707-3
Tumeurs de l'ovaire, 2000. ,
Impact de la stadification chirurgicale initiale sur le pronostic des cancers épithéliaux de l'ovaire de stade I et II, 2008. ,
Tumeurs de l'ovaire. Classification et histopathologie, Encycl Med Chir, pp.680-690, 1993. ,
Pathologie organique de l'ovaire, EMC - Radiologie et imagerie m??dicale - G??nito-urinaire - Gyn??co-obst??tricale - Mammaire, vol.1, issue.2 ,
DOI : 10.1016/S1879-8543(06)70640-1
Prédisposition génétique et cancer de l'ovaire, pp.34-600, 2004. ,
Epidémiologie des tumeurs de l'ovaire Gynécologie, 630-A-10 La micro-écologie des tumeurs épithéliales de l'ovaire, Encycl Med Chir Bull Cancer, vol.12, issue.9, pp.95-829, 2001. ,
Atteinte ganglionnaire dans le cancer épithélial de l'ovaire ,
(UFR des sciences médicales Bordeaux II, Bordeaux) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology, Int J Gynaecol Obstet, vol.146, issue.2, pp.70-209, 2000. ,
Mise au point sur les cancers de l???ovaire, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.37, issue.37 2, pp.69-74, 2008. ,
DOI : 10.1016/S0368-2315(08)75575-3
Quels sont les meilleurs critères de résécabilité dans les cancers de l'ovaire de stade avancé? Bull Cancer, pp.96-1189, 2009. ,
Cancer ??pith??lial de l'ovaire: bilan et chirurgie, EMC - Gyn??cologie, vol.1, issue.1, pp.630-640, 2000. ,
DOI : 10.1016/S0246-1064(00)00027-X
Chirurgie des tumeurs épithéliales malignes de l'ovaire Techniques chirurgicales - Gynécologie Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR), Encycl Med Chir Gynecol Oncol, vol.106, issue.1, pp.41-555, 2007. ,
EORTC???GCG process quality indicators for ovarian cancer surgery, European Journal of Cancer, vol.45, issue.4, pp.517-543, 2009. ,
DOI : 10.1016/j.ejca.2008.09.031
Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer, American Journal of Obstetrics and Gynecology, vol.197, issue.6, pp.197-676, 2007. ,
DOI : 10.1016/j.ajog.2007.10.495
Vers une évolution du dogme de la chirurgie "optimale" dans les cancers de l'ovaire, Bull Cancer, issue.12, pp.96-1175, 2009. ,
Classification et morbidités des chirurgies de résection dans les cancers de l'ovaire Intervention de Hudson (ovariectomie élargie) pour cancer de l'ovaire, Chirurgie des cancers gynécologiques, pp.73-80, 2009. ,
Traitement des pathologies tumorales du péritoine Gastro-entérologie, 9-120-A-60, Encycl Med Chir, pp.15-30, 2010. ,
Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer, Gynecologic Oncology, vol.105, issue.2, pp.409-422, 2007. ,
DOI : 10.1016/j.ygyno.2006.12.025
Effet de la voie d'abord sur la stadification chirurgicale des lésions ovariennes frontières et des cancers à un stade précoce, Bull Cancer, issue.7, pp.93-723, 2006. ,
Complete cytoreduction: is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?, Gynecol Oncol, issue.2, pp.78-176, 2000. ,
Cancer de l'ovaire de stade avancé : chirurgie initiale ou intervallaire ? Bull Cancer, pp.96-1183, 2009. ,
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer, New England Journal of Medicine, vol.363, issue.10, pp.943-53, 2010. ,
DOI : 10.1056/NEJMoa0908806
Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer 363(24): p. 2371-2; author reply 72. 37. Standards, Options: Recommandations pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l'ovaire. Traitement chirurgical (rapport intégral). FNCLCC, N Engl J Med, 2007. ,
Quality-of-Life Issues in the Management of Epithelial Ovarian Cancer, Current Treatment Options in Oncology, vol.101, issue.6, pp.402-418, 2007. ,
DOI : 10.1093/jnci/djg036
Facteurs pronostiques et chimioth??rapie de premi??re ligne des ad??nocarcinomes ovariens, EMC - Gyn??cologie, vol.1, issue.1 ,
DOI : 10.1016/S0246-1064(00)00033-5
Chimiothérapie de première ligne des adénocarcinomes ovariens de stade avancé, Bull Cancer, issue.12, pp.630-640, 2000. ,
Overview of anti-angiogenic agents in development for ovarian cancer, Gynecologic Oncology, vol.121, issue.1, pp.230-238, 2011. ,
DOI : 10.1016/j.ygyno.2010.11.035
Bases pharmacologiques de la chimiothérapie intrapéritonéale 45. Standards, Options: Recommandations pour la prise en charge des patientes atteintes de tumeurs épithéliales malignes de l'ovaire. Traitement médical de première ligne (rapport abrégé, mise à jour, Bull Cancer FNCLCC, issue.1212, pp.96-1235, 2008. ,
Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients, World J Surg, issue.9, pp.31-1813, 2007. ,
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis, British Journal of Cancer, vol.49, issue.suppl, pp.95-699, 2006. ,
DOI : 10.1006/gyno.1993.1085
Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial, JNCI: Journal of the National Cancer Institute, vol.97, issue.8, pp.97-560, 2005. ,
DOI : 10.1200/JCO.2001.19.7.1901
Les métastases ganglionnaires du cancer épithélial de l'ovaire sont elles chimiosensibles? Etude comparative de la lymphadénectomie première ou après chimiothérapie, Gynecol Obstet Fertil, issue.6, pp.32-502, 2004. ,
Lymphadénectomie lombo-aortique dans les cancers gynécologiques Gynécologie Curage ganglionnaire lomboaortique, Encycl Med Chir Chirurgie des cancers gynécologiques, pp.41-734, 2004. ,
Curages pelviens par laparotomie, EMC - Techniques chirurgicales - Gyn??cologie, vol.2, issue.1 ,
DOI : 10.1016/S1624-5857(07)73026-0
Technique des lymphadénectomies pelviennes laparoscopiques Techniques chirurgicales -Gynécologie Voie d'abord coelioscopique du curage lombo-aortique, Encycl Med Chir Gynecol Obstet Fertil, vol.38, issue.2, pp.41-732, 2005. ,
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial, The Lancet, vol.376, issue.9747, pp.98-575, 2009. ,
DOI : 10.1016/S0140-6736(10)61268-8
Surveillance et stratégie de traitement des rechutes de tumeurs de l'ovaire Gynécologie, 630-K-10 Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer, Encycl Med Chir Eur J Surg Oncol, issue.6, pp.36-583, 2001. ,
Récidives locorégionales du cancer de l'ovaire: place de la chirurgie, Bull Cancer, issue.11, pp.91-827, 2004. ,
Evaluation of survival date and two new rank order statistics arising in its consideration, Cancer Chemother Rep, vol.50, pp.163-70, 1966. ,
Nonparametric estimation from incomplete observations J Am Statist Soc, pp.457-81, 1958. ,
DOI : 10.1007/978-1-4612-4380-9_25
Analysis of survival data, 1990. ,
Ovarian cancer: Patterns of surgical care across the United States, Gynecologic Oncology, vol.103, issue.2, pp.383-90, 2006. ,
DOI : 10.1016/j.ygyno.2006.08.010
The effect of centralization of primary surgery on survival in ovarian cancer patients, Obstet Gynecol, vol.102, issue.3, pp.499-505, 2003. ,
Who should operate on patients with ovarian cancer? An evidence-based review, Gynecologic Oncology, vol.99, issue.2, pp.447-61, 2005. ,
DOI : 10.1016/j.ygyno.2005.07.008
What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?, Gynecologic Oncology, vol.82, issue.3, pp.489-97, 2001. ,
DOI : 10.1006/gyno.2001.6312
Influence of the Gynecologic Oncologist on the Survival of Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.6, pp.109-1342, 2007. ,
DOI : 10.1097/01.AOG.0000265207.27755.28
Quality control criteria in the surgical management of advanced ovarian cancers, Bull Cancer, vol.12, pp.1255-62, 2009. ,
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients, Gynecol Oncol Cancer, vol.107, issue.728, pp.92-154, 1998. ,
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?, Gynecologic Oncology, vol.103, issue.3, pp.797-801, 2006. ,
DOI : 10.1016/j.ygyno.2006.08.047
Assessing the adequacy of surgical staging for ovarian cancer, Gynecologic Oncology, vol.103, issue.3, pp.781-783, 2006. ,
DOI : 10.1016/j.ygyno.2006.10.017
Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer, Obstetrics & Gynecology, vol.107, issue.1, pp.77-85, 2006. ,
DOI : 10.1097/01.AOG.0000192407.04428.bb
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm, Gynecologic Oncology, vol.114, issue.1, pp.26-31, 2009. ,
DOI : 10.1016/j.ygyno.2009.03.018
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis, J Clin Oncol, issue.5, pp.20-1248, 2002. ,
Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium, Int J Gynecol Cancer, vol.10, issue.6, pp.435-477, 2000. ,
Pelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and Survival, Gynecologic Oncology, vol.74, issue.1, pp.7-11, 1999. ,
DOI : 10.1006/gyno.1999.5397
Lymph node surgery and ovarian cancer. e-mémoire Académ Nation Chir Lymph node metastasis in ovarian cancer: difference between serous and nonserous primary tumors of retroperitoneal lymph nodes in the treatment of ovarian cancer, Gynecol Oncol Int J Clin Oncol, vol.81, issue.823, pp.36-45, 2005. ,
Prise en charge chirurgicale des tumeurs ??pith??liales malignes de l???ovaire, Journal de Chirurgie, vol.141, issue.5, pp.277-84, 2004. ,
DOI : 10.1016/S0021-7697(04)95334-3
Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?, Annals of Surgical Oncology, vol.97, issue.1, pp.333-341, 2008. ,
DOI : 10.1016/0002-9378(86)90817-3
Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?, International Journal of Gynecological Cancer, vol.13, issue.3, pp.13-297, 2003. ,
DOI : 10.1046/j.1525-1438.2003.13192.x
Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer, International Journal of Gynecological Cancer, vol.17, issue.6, pp.17-1238, 2007. ,
DOI : 10.1111/j.1525-1438.2007.00931.x
Metastatic lymph node number in epithelial ovarian carcinoma: Does it have any clinical significance?, Gynecologic Oncology, vol.108, issue.2, pp.428-460, 2001. ,
DOI : 10.1016/j.ygyno.2007.09.014
Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer, American Journal of Obstetrics and Gynecology, vol.195, issue.6, pp.1862-1870, 0195. ,
DOI : 10.1016/j.ajog.2006.06.068
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13???918 patients, British Journal of Cancer, vol.95, issue.12, pp.96-1817, 2007. ,
DOI : 10.1046/j.1525-1438.2003.13192.x
The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database, BJOG: An International Journal of Obstetrics & Gynaecology, vol.202, issue.12, pp.117-1451, 2010. ,
DOI : 10.1016/0002-9378(86)90817-3
Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables, Gynecologic Oncology, vol.97, issue.2, pp.97-400, 2005. ,
DOI : 10.1016/j.ygyno.2005.01.038
Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report, Lasers in Medical Science, vol.7, issue.3, pp.131-136, 2007. ,
DOI : 10.1007/s10103-006-0428-4
Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects, International Journal of Gynecological Cancer, vol.17, issue.1, pp.68-75, 2007. ,
DOI : 10.1111/j.1525-1438.2006.00777.x
Role of appendectomy in predicting lymph node metastases in patients with ovarian cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.88, issue.2, pp.159-63, 2000. ,
DOI : 10.1016/S0301-2115(99)00151-7
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases, Gynecologic Oncology, vol.89, issue.1, pp.9-15, 2003. ,
DOI : 10.1016/S0090-8258(02)00147-6
Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer, Gynecologic Oncology, vol.94, issue.1, pp.94-161, 2004. ,
DOI : 10.1016/j.ygyno.2004.04.023
Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications, Journal of the American College of Surgeons, vol.197, issue.2, pp.198-205, 2003. ,
DOI : 10.1016/S1072-7515(03)00234-5
Pelvic and aortic lymph node metastasis in epithelial ovarian cancer, Gynecologic Oncology, vol.105, issue.3, pp.604-612, 2007. ,
DOI : 10.1016/j.ygyno.2007.01.028
A systematic review of tests for lymph node status in primary endometrial cancer, BMC Women's Health, vol.181, issue.1, p.8, 2008. ,
DOI : 10.1148/radiology.181.1.1887062
Lymph nodes in gynecologic oncology: Enduring importance and challenge, International Journal of Gynecology & Obstetrics, vol.99, issue.(1), pp.1-2, 2009. ,
DOI : 10.1016/j.ijgo.2007.06.001
Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, Gynecologic Oncology, vol.121, issue.2, 2011. ,
DOI : 10.1016/j.ygyno.2010.12.328
Curage ganglionnaire pelvien, Chirurgie des cancers gynécologiques, pp.148-58, 2009. ,
Généralités sur la chirurgie ganglionnaire, Chirurgie des cancers gynécologiques, pp.141-146, 2009. ,
Role of lymphadenectomy in ovarian cancer, Best Practice & Research Clinical Obstetrics & Gynaecology, vol.16, issue.4, pp.529-51, 2002. ,
DOI : 10.1053/beog.2002.0301
La lymphad??nectomie lombo-aortique et pelvienne dans les cancers ??pith??liaux de l'ovaire. A propos d'une s??rie de 86 cas, Annales de Chirurgie, vol.125, issue.2, pp.125-163, 2000. ,
DOI : 10.1016/S0003-3944(00)00233-9
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer, pp.110-1235, 2007. ,
Que reste-t-il du??curage lomboaortique dans??le??traitement du??cancer du??testicule?, Annales d'Urologie, vol.41, issue.3, pp.41-116, 2007. ,
DOI : 10.1016/j.anuro.2007.04.002
Does paraaortic lymphadenectomy have a benefit in the treatment of ovarian cancer??that is apparently confined to the ovaries?, European Journal of Cancer, vol.37, issue.2, pp.210-215, 2001. ,
DOI : 10.1016/S0959-8049(00)00377-4
L'avenir de la dissection ganglionnaire rétropéritonéale, J Gynecol Obstet Biol Reprod, vol.29, issue.3, pp.276-284, 2000. ,
Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies, Gynecol Oncol, issue.116, pp.1225-1266, 2009. ,
Pelvic lymphocysts following retroperitoneal lymphadenectomy: Retroperitoneal partial ???no-closure??? for ovarian and endometrial cancers, Journal of Surgical Oncology, vol.161, issue.3, pp.149-52, 1998. ,
DOI : 10.1016/0002-9378(89)90757-6
Retroperitoneal Drainage After Complete Para-aortic Lymphadenectomy for Gynecologic Cancer, Obstetrics & Gynecology, vol.97, issue.2, pp.97-243, 2001. ,
DOI : 10.1097/00006250-200102000-00015
Lymphedema after gynecological cancer treatment, Cancer, vol.33, issue.12, pp.2607-2621, 2007. ,
DOI : 10.1016/S0894-1130(01)80043-0
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.22684/pdf
Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer, The Australian and New Zealand Journal of Obstetrics and Gynaecology, vol.18, issue.2, pp.43-148, 2003. ,
DOI : 10.1006/gyno.1999.5660
Chylous ascites following para-aortic lymphadenectomy: a case report, Gynecologic Oncology, vol.93, issue.3, pp.93-711, 2004. ,
DOI : 10.1016/j.ygyno.2004.03.022
Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.1, pp.12-21, 2007. ,
DOI : 10.1097/01.AOG.0000249610.95885.ef
Association of Lymphadenectomy and Survival in Stage I Ovarian Cancer Patients, Obstetrics & Gynecology, vol.109, issue.4, pp.1000-1001, 2007. ,
DOI : 10.1097/01.AOG.0000260085.24403.b3
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial, JNCI Journal of the National Cancer Institute, vol.37, issue.3, pp.95-113, 2003. ,
DOI : 10.1016/0090-8258(90)90370-Z
The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer, Journal of Obstetrics and Gynaecology Research, vol.97, issue.5, pp.36-1023, 2010. ,
DOI : 10.1097/01.AOG.0000249610.95885.ef
The place of lumbo-aortic lymph node dissection in the treatment of ovarian cancer, J Chir, issue.145 4, pp.12-45, 2008. ,
Management of retroperitoneal lymph nodes in advanced ovarian cancer, International Journal of Gynecological Cancer, vol.18, issue.1, pp.7-10, 2008. ,
DOI : 10.1111/j.1525-1438.2007.01097.x
Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease, Aust N Z J Obstet Gynaecol, vol.39, issue.4, pp.420-424, 1999. ,
Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study, Journal of Surgical Oncology, vol.78, issue.3, pp.81-132, 2002. ,
DOI : 10.1002/jso.1158
Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial, J Clin Oncol, issue.34, pp.23-8802, 2005. ,
Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer, Gynecologic Oncology, vol.93, issue.3, pp.93-647, 2004. ,
DOI : 10.1016/j.ygyno.2004.03.006
Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy, Cancer Sci, issue.10, pp.100-1191, 2009. ,
Outcomes After Combined Therapy Including Surgical Resection in Patients with Epithelial Ovarian Cancer Recurrence(s) Exclusively in Lymph Nodes, Annals of Surgical Oncology, vol.13, issue.7, pp.11-658, 2004. ,
DOI : 10.1245/ASO.2004.11.023
Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery, Int J Gynecol Cancer, issue.6, pp.17-1245, 2007. ,
Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers Bull Cancer, pp.96-1163, 2009. ,
Systematic Lymphadenectomy in Advanced Epithelial Ovarian Cancer: Two Decades of Uncertainty Resolved, JNCI: Journal of the National Cancer Institute, vol.97, issue.8, pp.548-557, 2005. ,
DOI : 10.1200/JCO.2002.20.19.3944
Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors, Gynecologic Oncology, vol.104, issue.1, pp.41-46, 2007. ,
DOI : 10.1016/j.ygyno.2006.06.039
Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node Ratio, Annals of Surgery, vol.248, issue.6, pp.248-968, 2008. ,
DOI : 10.1097/SLA.0b013e318190eddc
Faut-il arr??ter les curages lombo-aortiques syst??matiques dans les cancers de l???ovaire???, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.35-1167, 2007. ,
DOI : 10.1016/j.gyobfe.2007.09.007
The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?, British Journal of Cancer, vol.322, issue.7, pp.98-1191, 2008. ,
DOI : 10.1056/NEJM199004123221501
Pour ou contre le curage lombo-aortique dans les cancers de l???ovaire???, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.35-1166, 2007. ,
DOI : 10.1016/j.gyobfe.2007.09.005
Contre le curage lomboaortique syst??matique dans la prise en charge des cancers de l???ovaire, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.11, pp.1170-1171, 2007. ,
DOI : 10.1016/j.gyobfe.2007.09.006
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials, J Clin Oncol, issue.10, pp.28-1733, 2010. ,
Systematic Lymphadenectomy for Survival in Epithelial Ovarian Cancer, International Journal of Gynecological Cancer, vol.19, issue.4, pp.520-528, 2010. ,
DOI : 10.1111/IGC.0b013e3181d6de1d
Impact des curages r??trop??riton??aux sur la survie des patientes atteintes d???un cancer de l???ovaire ?? un stade avanc????: le protocole CARACO, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.40, issue.3, 2011. ,
DOI : 10.1016/j.jgyn.2011.02.009
Cancer de l'ovaire à un stade avancé: la place des curages ganglionnaires, Bull Cancer, vol.97, issue.1, pp.65-71, 2010. ,